An English study finds a reduced risk of cervical cancer recurrence after HPV vaccination after surgery, although further research is needed to confirm this finding.
Precancerous lesions correspond to changes in the cells of the epithelium of the cervix, in other words the tissue that covers it. These lesions have the particularity of being able to develop into cancer. It is not always necessary to treat a precancerous lesion. Depending on its severity, two options are possible as explained by the National Institute against Cancer (Inca): monitor the lesion until it heals spontaneously (which happens most often) or remove it. When the lesion must be treated, the choice of treatment must take into account the patient’s desire for pregnancy. Whatever treatment is performed, the goal is to remove the abnormal cells to prevent the lesions from progressing to cancer. In this field, a study has just shown that giving women the vaccine against the human papillomavirus (HPV) when precancerous lesions are removed from the cervix can reduce the risk of cell recurrence and cancer of the cervix. cervix. The study by researchers at Imperial College London published in the British Medical Journal thus suggests the vaccine could have a second key role in the fight against cervical cancer.
So giving a dose to women when they’re having surgery to remove precancerous cells could…
Read more on Femina.fr